This article was originally published in The Gray Sheet
Executive SummaryFDA approves the Puritan-Bennett Achieva portable volume ventilator. Suitable for children and adults, Achieva's "enhanced performance and pressure support capabilities bring Mallinckrodt full force into the subacute market," the firm says. The device also features "extended battery life," internal memory and modem for accessing stored data. Separately, Mallinckrodt's Nellcor N-395 pulse oximeter with Oxismart XL advanced signal processing and SatSeconds alarm management technology gains additional 510(k) clearance for use with Nellcor Oxisensor II adhesive sensors. The device was originally cleared in August to read through motion and deliver accurate oxygen saturation and pulse rate values using Nellcor adult and neonatal sensors. The expanded clearance extends the motion claim to include Nellcor pediatric and infant sensors
You may also be interested in...
Deal Snapshot: AstraZeneca has sublicensed global rights to its peripheral mu-opioid receptor antagonist to RedHill Biopharma, excluding Europe, Canada and Israel, with RedHill also separately receiving non-dilutive financing from HealthCare Royalty Partners.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.